Takeda Expands Abroad While Finding Its Way In Its Home Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Takeda announces cross-licensing deals with Dainippon Sumitomo in a rights swap in Europe and Japan that involves ceftaroline and lurasidone.